Search research articles
Contact Us
Filters
Showing results (11-20 of 35) with videos related to
Page
of 4
Sort By:
European Journal of Clinical Investigation
|
April 20, 2016
Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study
Christian L Hvas, Anders Dige, Mia Bendix, et al.
Inflammopharmacology
|
January 24, 2013
25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease
Lars E Bartels, Søren P Jørgensen, Mia Bendix, et al.
Inflammopharmacology
|
December 31, 2013
Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients
Lars E Bartels, Mia Bendix, Christian L Hvas, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
October 10, 2022
Standardised survival and excess Life Years Lost in patients with type 3 intestinal failure
Maja Kopczynska, Christian L Hvas, Peter Jepsen, et al.
Nutrients
|
April 12, 2022
Long-Term Outcomes in Patients with Intestinal Failure Due to Short Bowel Syndrome and Intestinal Fistula
Maja Kopczynska, Gordon Carlson, Antje Teubner, et al.
Oncotarget
|
April 17, 2017
Vitamin D increases programmed death receptor-1 expression in Crohn's disease
Mia Bendix, Stinne Greisen, Anders Dige, et al.
Diseases of the Colon and Rectum
|
November 22, 2021
Patient-Reported Outcomes and Health-Related Quality of Life in People Living With Ileostomies: A Population-Based, Cross-Sectional Study
Charlotte L Rud, Simon M D Baunwall, Palle Bager, et al.
Journal of Crohn'S & Colitis
|
July 13, 2012
Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease
Anders Dige, Sidsel Støy, Tue K Rasmussen, et al.
Plos One
|
April 13, 2011
Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?
Jens Kelsen, Anders Dige, Heinrich Schwindt, et al.
The British Journal of Nutrition
|
September 24, 2020
Casein glycomacropeptide is well tolerated in healthy adults and changes neither high-sensitive C-reactive protein, gut microbiota nor faecal butyrate: a restricted randomised trial
Pernille G Wernlund, Christian L Hvas, Jens F Dahlerup, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 35) with videos related to
Sort By:
Page
of 4
European Journal of Clinical Investigation
|
April 20, 2016
Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study
Christian L Hvas, Anders Dige, Mia Bendix, et al.
Inflammopharmacology
|
January 24, 2013
25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease
Lars E Bartels, Søren P Jørgensen, Mia Bendix, et al.
Inflammopharmacology
|
December 31, 2013
Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn's disease patients
Lars E Bartels, Mia Bendix, Christian L Hvas, et al.
Clinical Nutrition (Edinburgh, Scotland)
|
October 10, 2022
Standardised survival and excess Life Years Lost in patients with type 3 intestinal failure
Maja Kopczynska, Christian L Hvas, Peter Jepsen, et al.
Nutrients
|
April 12, 2022
Long-Term Outcomes in Patients with Intestinal Failure Due to Short Bowel Syndrome and Intestinal Fistula
Maja Kopczynska, Gordon Carlson, Antje Teubner, et al.
Oncotarget
|
April 17, 2017
Vitamin D increases programmed death receptor-1 expression in Crohn's disease
Mia Bendix, Stinne Greisen, Anders Dige, et al.
Diseases of the Colon and Rectum
|
November 22, 2021
Patient-Reported Outcomes and Health-Related Quality of Life in People Living With Ileostomies: A Population-Based, Cross-Sectional Study
Charlotte L Rud, Simon M D Baunwall, Palle Bager, et al.
Journal of Crohn'S & Colitis
|
July 13, 2012
Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease
Anders Dige, Sidsel Støy, Tue K Rasmussen, et al.
Plos One
|
April 13, 2011
Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?
Jens Kelsen, Anders Dige, Heinrich Schwindt, et al.
The British Journal of Nutrition
|
September 24, 2020
Casein glycomacropeptide is well tolerated in healthy adults and changes neither high-sensitive C-reactive protein, gut microbiota nor faecal butyrate: a restricted randomised trial
Pernille G Wernlund, Christian L Hvas, Jens F Dahlerup, et al.
Page
of 4